Peptide Therapeutics Cambridge Pages on BioPortfolio:

BioPortfolio News: - Bicycle Therapeutics and Pepscan Enter...
... the weaknesses of previous generations of peptide based therapeutics and combine ... Bicycle Therapeutics is a biotechnology company based in Cambridge,
...
http://www.bioportfolio.com/news/Bicycle-Therapeutics-and-Pe...

BioPortfolio.com - BioWeb Type II Diabetes Diabetes Search
RA Corixa peptide rheumatoid arthritis Phase II Seattle, ... idiopathic pulmonary fibrosis Phase II interferon beta- 1a Cambridge, MA (see also cancer,
... A N N U A L R E P O RT 2 0 0 0 DEVELOPING TOMORROW'S HUMAN THERAPEUTICS >
Focus ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio News: - Mersana Therapeutics Publishes Review...
12 Nov 2009 ... CAMBRIDGE, Massachusetts, November 12 /PRNewswire/ -- Mersana ... biologics such as siRNA and peptide therapeutics to transform existing and ...
http://www.bioportfolio.com/news/Mersana-Therapeutics-Publis...

Peptides 2006: New Applications in Discovery, Manufacturing, and ...
peptide therapeutics, individual product examples, improved drug delivery .... Cambridge. Chief Shareholder ALZA (9.7%). MA 02139. Total Staff 360 ...
http://www.bioportfolio.com/cgi-bin/acatalog/9214_peptides.p...

Coopers & Lybrand February 98 BioScience Index
6 Peptide Therapeutics 7 Tepnel Life Sciences 8 Cantab Pharmaceuticals 9 Vanguard Medica 10 Alizyme 11 Polymasc Pharmaceuticals 12 Xenova 13 Cambridge
...
http://www.bioportfolio.com/pwc/coopers/february98.htm...

Lab21 Announces Licence Agreement with Ark Therapeutics for ...
Lab21 Announces Licence Agreement with Ark Therapeutics for Predictive Coronary Heart Disease Diagnostic. Cambridge, 11th October … ...
http://www.bioportfolio.com/biotech_news/Lab21_8.htm...

PriceWaterhouseCoopers BioScience Index and Share League November ...
Cambridge Antibody. 49.44. 16. (14). PolyMASC Pharmaceuticals. 44.49. 17. (17). Peptide Therapeutics. 39.85. 18. (19). Tepnel Life Sciences ...
http://www.bioportfolio.com/pwc/coopers/january99.htm...

BioPortfolio - Wellstat Therapeutics Corporation - Profile
Mersana Therapeutics,. Inc. CAMBRIDGE, Mass., Nov. 17 ... 6858583- Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation ...
http://www.bioportfolio.com/biocorporate/28643-Wellstat+Ther...

BioPortfolio - Proteom - Proteom establishes business partnership ...
Proteom, based in Cambridge UK, is a bioinformatics company which is defining the ... technology to design peptide ligands (as therapeutics, the basis for ...
http://www.bioportfolio.com/news/Proteom_establishes_busines...

Results from other life science and pharmaceutical sites:

BioSpace - Peptide Therapeutics Group PLC News, Search Jobs, Events
Peptide Therapeutics Group PLC Peterhouse Technology Park 100 Fulbourn Road Cambridge CB19PT United Kingdom Phone: 44-1223-275300 Fax: 44-1223-416300 ...
http://www.biospace.com/company_profile.aspx?CompanyId=88792...

The route of administration of an immunodominant peptide derived ...
J.N.F. was in receipt of a PhD. studentship funded by Peptide Therapeutics Ltd., Cambridge (UK). S.J.T. was in receipt of an ARC Research Fellowship. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2327169/...

Is consolidation the only option for UK biotech? : Article ...
Peptide Therapeutics (Cambridge, UK) has announced the acquisition of OraVax ( Cambridge, MA), an American rival. Cantab Pharmaceuticals (Cambridge, UK) has
...
http://www.nature.com/bioent/2003/030101/full/nbt0599supp_31...

The route of administration of an immunodominant peptide derived ...
Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, and Peptide Therapeutics Ltd, Cambridge, UK. ...
http://www.ncbi.nlm.nih.gov/pubmed/10712662...

Peptides that block hepatitis B virus assembly: analysis by ...
... Peptide Therapeutics, 321 Cambridge Science Park, Milton Road, Cambridge CB4 4WG, ... of virus in the presence of peptide, in a dose-dependent manner. ...
http://www.nature.com/emboj/journal/v17/n23/abs/7591373a.htm...

Characterisation of a mouse monoclonal anti-idiotype reactive with ...
2Immunology Division, Department of Pathology, Cambridge University, Tennis Court ... by Professor D Stanworth (Peptide Therapeutics plc, Cambridge, UK).
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1186909/...

Accelrys
Richard Scott of Peptide Therapeutics, Cambridge, UK has used Acelrys' Catalyst software in work to develop a Meningitis B vaccine. ...
http://accelrys.com/references/case-studies/archive/studies/...

The kinetic and structural characterization of the reaction of ...
Peptide Therapeutics, Cambridge, UK. manoj.ramjee@peptide.co.uk. Nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor, is active against a
...
http://www.ncbi.nlm.nih.gov/pubmed/10899355...

Confronting consolidation issues: Is this the right move for you ...
Perhaps the best recent example is Peptide Therapeutics' (Cambridge, UK) acquisition of OraVax, effecting the combination of complementary bacterial and
...
http://www.nature.com/bioent/2003/030101/full/nbt0299supp_27...

IL-12: a key cytokine in immune regulation.
Peptide Therapeutics, Cambridge, UK. alanla@peptide.co.uk. It is now apparent that interleukin 12 (IL-12) is of central significance in the regulation of ...
http://www.ncbi.nlm.nih.gov/pubmed/8991382...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.